However, the respiratory quotient has also been reported to be increased by central SST actions independent of the orexigenic effects (80)
While the drug has been on the mainland China market since 2021, its recent success can be attributed to the growing enthusiasm towards GLP-1 drugs that offer promising weight loss benefits
no controlled semaglutide vaginal pain incidence signal in labelling
Starting at low doses and gradually increasing allows your body to adapt to the medication effects on gastric emptying, insulin secretion, and appetite regulation
Keep your patients comfortable, engaged, and hopeful
At my own weight loss practice seeing patients at Bariendo, I do occasionally prescribe GLP1 medications within certain parameters